Abstract
Introduction
Neglected diseases (NDs) affect more than 1 billion people worldwide and are responsible by deaths of more than one million people annually (MACKEY; LIANG, 2012; ROSALES-MENDOZA et al., 2012) . The NDs have several characteristics in common, being main the poverty, lack of sanitation and health services. Among the NDs (Figure 1 ) more prevalent, can quote the lymphatic filariasis, hookworm, malaria, onchocerciasis, trachoma, leishmaniasis, chagas disease and schistosomiasis, in which are needed new drugs of low-cost, safe and effective (YAJIMA et al., 2012) . The treatment of many NDs imposes financial charges and therefore there is little incentive on the private market to develop new treatments, being exactly one fundamental problem as induce pharmaceutical companies to invest resources for the development of medicines that treat DNs. The problem arises because the majority of NDs mainly affects the poorest part of the world population and even with potential demand for new medicines, the pharmaceutical industries resist in make investments, since the market value of the medicines is low and because the affected can not afford by medications (DIMITRI, 2012; JANSEN et al., 2012; RIDLEY; SÁNCHEZ, 2010) . Therefore, there is an increasing need for developing new medicines and nature by means of plants has provided countless numbers of new bioactive chemicals that can be used to treat of many diseases, among them, the DNs. Natural compounds and derivatives as phenolics, coumarins, quinones, alkaloids, saponins and terpenoid have been reported in the scientific literature as D.O.I.: 10.7198/S2237-0722201400030013 promising drugs for the treatment of various NDs (SCHMIDT et al., 2012b; SEN; CHATTERJEE, 2011) .
Besides of the natural compounds discussed in the previous paragraph, can be cited the substances belonging to the group of phenolic compounds such as neoflavonoids. The neoflavonoids possess several pharmacological and biochemical properties and are present in a wide variety of higher plant of families Clusiaceae, Fabaceae, Rubiaceae, Thelypteridaceae, Passifloraceae, Asteraceae and Rutaceae, being that up to the present moment, more than 1000 structurally distinct neoflavonoids has been described (GARAZD; GARAZD; KHILYA, 2003) .
Even with few chemical structures identified until the present moment, there are already scientific studies confirming that these compounds and their derivatives can be highlighted as promising medications for the treatment of NDs (SCHMIDT et al., 2012a; VEROTTA et al., 2004) .
The neoflavonoides represent a group of natural compounds that possessing as basic structure characteristic the 4-phenylcoumarin, in which is represented by Figure 2 . The objective of this work was perform a technological forecasting on the neoflavonoids and its implications with relation to treatment of NDs, being that for this, will be used information available in scientific and technology databases national and international. Therefore, the present may facilitate and guide future research with respect to the use of neoflavonoids for the treatment of NDs. The focus of this research was the use of neoflavonoids with implications in the treatment of NDs, and per this, the key words used were the terms neoflavonoids and 4-phenylcoumarin. The combinations of terms, "neoflavonoids and neglected diseases" and "4-phenylcoumarin and neglected diseases", were also used for the development of this work. The references found during the realization of this research were studied in detail.
Methodology
The term 4-phenylcoumarin was used as key word per be the basic structure of neoflavonoids and by that many scientific papers using the name 4-phenylcoumarin instead of neoflavonoides in the title of scientific work. The terms in english were used for international databases, while the terms in portuguese were used to search of documents in national basis, being considered valid documents that presented these terms in the title and/or abstract.
Results and Discussion

Results of prospecting of documents found in portal of the periodicals of CAPES, Science
Direct, Scopus, Pub Med, Web of Science and ACS Publications.
Using the keyword neoflavonoids and 4-phenylcoumarin in field "search subject" on Portal of journals of Capes, were found respectively 178 and 188 documents. Of 178 documents found Using the combinations of terms "neoflavonoids and neglected diseases" and "4-phenylcoumarin and neglected diseases", were found a total of 7 documents and only 1 document addresses the use of neoflavonoides in treatment of neglected diseases. Analyzing the documents found regarding the keyword neoflavonoids, was observed that out of the total of 474 documents, 5
shows possible implications of neoflavonoids in treatment of neglected diseases. Using the keyword 4-phenylcoumarin, were found 743 documents, being that of this total, 8 attributed pharmacological
properties of neoflavonoids in treatment of neglected diseases. In Table 2 are summarized some scientific studies that indicates the use of these natural compounds as promising drugs for the treatment of several neglected diseases. D.O.I.: 10.7198/S2237-0722201400030013 Table 2 -Neoflavonoids with implications for the treatment of neglected diseases.
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Results of prospecting of patents found in INPI, EPO, USPTO, WIPO e SIPO.
Many technological information can be found in publications of patents, which are regarded as an essential source of scientific knowledge and technology that has information about the publication number, registration number, title of the invention, the name of the inventor, international classification of patents (ICP), summary and a detailed description of the invention and claims (MONTECCHI; RUSSO; LIU, 2013).
During the realization of this research, it was found only 1 request for deposit of patent at basis of the INPI, 3 deposits of patents at basis of the EPO, 3 at base of the WIPO and 2 at base of the SIPO, totalizing 9 requests of deposits of patents for the keyword neoflavonoids (Table 3) . With respect to the term 4-phenylcoumarin, we found no patent application in databases of the INPI, EPO, WIPO, USPTO and SIPO. The data set in Table 2 demonstrate that there is a greater quantity of documents for the keyword 4-phenylcoumarin than for the word neoflavonoids. However, unlike the data set out in Table 2 , no deposit of patent application in databases of the INPI, EPO, USPTO, WIPO and SIPO was found for the term 4-phenylcoumarin (Table 3 ), indicating that the dissemination of scientific knowledge with respect to the term 4-phenylcoumarin occurs mainly through the publication of scientific articles. It is observed in Table 3 no deposit of patent application in databases of the INPI, EPO, USPTO, WIPO and SIPO, when it is using the combinations of terms "neoflavonoids and neglected diseases" and "4-phenylcoumarin and neglected diseases".
A more specific analysis of patents found in base of the INPI, EPO, WIPO and SIPO is described in Table 4 with the number, year, title and abstract of the patent. It was observed that the D.O.I.: 10.7198/S2237-0722201400030013 deposits of patent applications found at the base of WIPO are the same documents deposited at the base of the EPO. 
Conclusion
Through this exploration, it was possible to analyze the studies published on websites of the CAPES, Science Direct, Scopus, Pub Med, ACS Publications, INPI, EPO, WIPO, USPTO and SIPO regarding neoflavonoids and its implications for the treatment of NDs. Thus, it is observed that the majority of documents is published in the form of scientific articles, and a small fraction in the form of filing patent applications.
Despite being few studied when compared with other classes of compounds, as observed in the present study, the neoflavonoids can be of great interest to the pharmaceutical industries. The neoflavonoids presented therapeutic implications for malaria, leishmaniasis and American trypanosomiasis (Chagas Disease), thus providing new opportunities for the development of new bioactive compounds that may in future be used to treat NDs.
Moreover, this prospecting can serve as an incentive for technological innovation for the development of new research involving neoflavonoids, since the number of deposits of patent applications is relatively low.
